Single and multiple ascending dose of ZP9830 in healthy participants
ZP9830-23005
Phase 1 other active
Quick answer
Single and multiple ascending dose of ZP9830 in healthy participants for Autoimmune diseases is a Phase 1 program (other) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zealand Pharma A/S
- Indication
- Autoimmune diseases
- Phase
- Phase 1
- Modality
- other
- Status
- active